Table 1.
Baseline Patient Characteristics
| Characteristics | N=66 |
|---|---|
| Age, (years)* | 58(28–80) |
| Sex, (male/female) | 43/23 (65.2%/34.8%) |
| Performance status, (0/1/2) | 4/28/34 (6.1%/42.4%/51.5%) |
| GOOSS, (0/1/2) | 15/20/31 (22.7%/30.3%/47.0%) |
| NRS 2002 scale | |
| ≤3 | 1 (1.5%) |
| >3 | 65 (98.5%) |
| PG-SGA category | |
| B | 4 (6.1%) |
| C | 62 (93.9%) |
| PNI | |
| <45 | 48 (72.7%) |
| ≥45 | 18 (27.3%) |
| NLR | |
| <2.5 | 20 (30.3%) |
| ≥2.5 | 46 (69.7%) |
| Overall QOL* | 6(4–9) |
| Body composition | |
| BMI (kg/m2)* | 21.7(17.3–26.4) |
| SMI (cm2/m2)* | 48.8(33.4–65.4) |
| Sarcopenia | 24 (36.4%) |
| cT | |
| T3 | 6 (9.1%) |
| T4 | 60 (90.9%) |
| cN(+) | 66 (100%) |
| Non-curable factor | |
| Tumour infiltration to adjacent organs | 7 (10.6%) |
| Peritoneal metastasis | 35 (53.0%) |
| Hepatic metastasis | 16 (24.2%) |
| Distant lymph nodes metastasis | 39 (59.1%) |
| Laparoscopic gastrojejunostomy | |
| Present | 35 (53.0%) |
| Absent | 31 (47.0%) |
Note: *Median (range).
Abbreviations: GOOSS, gastric outlet obstruction scoring system; 0, no oral intake; 1, liquids only; 2, soft food, 3, solid food; NRS 2002, Nutrition Risk Screening 2002; PG-SGA, Patient-Generated Subjective Global Assessment; PNI, Prognostic Nutritional Index; NLR, Neutrophil to lymphocyte ratio; QOL, Quality of life; BMI, body mass index; SMI, skeletal muscle index.